FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Medical Groups Want FDA Compounding Discretion

21 physician organizations ask FDA not to finalize a guidance on insanitary conditions in drug compounding facilities in a way that would restrict the...

Federal Register

Zonegran Not Withdrawn Due to Safety/Efficacy: FDA

Federal Register notice: FDA determines that Sunovion Pharmaceuticals Zonegran (zonisamide) was not withdrawn for safety or effectiveness reasons.

Human Drugs

Trump Orders VA Spravato Purchase

President Donald Trump orders the Veterans Administration to obtain supplies of Johnson & Johnsons Spravato for use with suicidal veterans.

FDA General

FDA Didnt Submit OIG Clearance Documents: Report

The HHS Inspection General says FDA is making progress in submitting clearance documents for FY 2015 and 2016 audit recommendations.

Human Drugs

End Mifepristone Distribution Restrictions: Authors

Former FDA commissioner Jane Henney and Chicago Community Fund CEO Helene Gayle urge FDA to reevaluate the distribution restrictions currently in plac...

Human Drugs

Regeneron Seeks Heart Failure Guidance Clarifications

Regeneron asks FDA to clarify a draft guidance on developing endpoints for testing drugs intended to treat heart failure.

Human Drugs

Risk-Based Inspection Approach Explained

The Avoca Group explains the elements involved in taking a risk-based approach to clinical trial inspection readiness.

Human Drugs

Updated COA Compendium Out

FDA issues an updated Clinical Outcome Assessment Compendium for use in determining how clinical outcome assessments may be used in clinical trials.

Human Drugs

Drug Co. Charged with Unfairly Disclosing FDA Info

SEC charges TherapeuticsMD with selectively sharing information with stock analysts after meeting with FDA on a product development issue.

Federal Register

Joint Panel to Review Pediatric-use Opioids

Federal Register notice: FDA announces a 9/26 joint advisory committee meeting to discuss the pediatric-focused safety review for oxycodone hydrochlor...